198 related articles for article (PubMed ID: 34128588)
1. Interleukin-25: New perspective and state-of-the-art in cancer prognosis and treatment approaches.
Gowhari Shabgah A; Amir A; Gardanova ZR; Olegovna Zekiy A; Thangavelu L; Ebrahimi Nik M; Ahmadi M; Gholizadeh Navashenaq J
Cancer Med; 2021 Aug; 10(15):5191-5202. PubMed ID: 34128588
[TBL] [Abstract][Full Text] [Related]
2. Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors.
Benatar T; Cao MY; Lee Y; Li H; Feng N; Gu X; Lee V; Jin H; Wang M; Der S; Lightfoot J; Wright JA; Young AH
Cancer Immunol Immunother; 2008 Dec; 57(12):1757-69. PubMed ID: 18351336
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer.
Bastid J; Dejou C; Docquier A; Bonnefoy N
Front Immunol; 2020; 11():718. PubMed ID: 32373132
[TBL] [Abstract][Full Text] [Related]
4. Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer.
Ma YF; Chen C; Li D; Liu M; Lv ZW; Ji Y; Xu J
Oncotarget; 2017 Jan; 8(5):7614-7624. PubMed ID: 27935862
[TBL] [Abstract][Full Text] [Related]
5. Chemokine CXCL14; a double-edged sword in cancer development.
Gowhari Shabgah A; Haleem Al-Qaim Z; Markov A; Valerievich Yumashev A; Ezzatifar F; Ahmadi M; Mohammad Gheibihayat S; Gholizadeh Navashenaq J
Int Immunopharmacol; 2021 Aug; 97():107681. PubMed ID: 33932697
[TBL] [Abstract][Full Text] [Related]
6. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
7. Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma.
Luo Y; Yang Z; Su L; Shan J; Xu H; Xu Y; Liu L; Zhu W; Chen X; Liu C; Chen J; Yao C; Cheng F; Zhang C; Ma Q; Shen J; Qian C
Cancer Lett; 2016 Jun; 375(2):390-399. PubMed ID: 27000993
[TBL] [Abstract][Full Text] [Related]
8. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.
Liu L; Ge D; Ma L; Mei J; Liu S; Zhang Q; Ren F; Liao H; Pu Q; Wang T; You Z
J Thorac Oncol; 2012 Jul; 7(7):1091-100. PubMed ID: 22534817
[TBL] [Abstract][Full Text] [Related]
10. IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.
Mombelli S; Cochaud S; Merrouche Y; Garbar C; Antonicelli F; Laprevotte E; Alberici G; Bonnefoy N; Eliaou JF; Bastid J; Bensussan A; Giustiniani J
Sci Rep; 2015 Jul; 5():11874. PubMed ID: 26154409
[TBL] [Abstract][Full Text] [Related]
11. Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-γ.
Okuyama H; Tominaga A; Fukuoka S; Taguchi T; Kusumoto Y; Ono S
Oncol Rep; 2017 Feb; 37(2):684-694. PubMed ID: 28075473
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment.
Zhang Q; Liu S; Zhang Q; Xiong Z; Wang AR; Myers L; Melamed J; Tang WW; You Z
Prostate; 2014 Jun; 74(8):869-79. PubMed ID: 24691769
[TBL] [Abstract][Full Text] [Related]
13. IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma.
Xu QG; Yu J; Guo XG; Hou GJ; Yuan SX; Yang Y; Yang Y; Liu H; Pan ZY; Yang F; Gu FM; Zhou WP
Mol Oncol; 2018 Jun; 12(6):936-952. PubMed ID: 29689643
[TBL] [Abstract][Full Text] [Related]
14. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract][Full Text] [Related]
15. The interplay of interleukin-17A and breast cancer tumor microenvironment as a novel immunotherapeutic approach to increase tumor immunogenicity.
Moaaz M; Lotfy H; Motawea MA; Fadali G
Immunobiology; 2021 Mar; 226(2):152068. PubMed ID: 33556742
[TBL] [Abstract][Full Text] [Related]
16. Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer.
Qian XL; Xu P; Zhang YQ; Song YM; Li YQ; Li WD; Jiang CY; Shen BB; Zhang XM; Zhang LN; Fu L; Guo XJ
Breast Cancer Res Treat; 2020 Apr; 180(2):311-319. PubMed ID: 31993861
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-35 has a tumor-promoting role in hepatocellular carcinoma.
Liu X; Ren H; Guo H; Wang W; Zhao N
Clin Exp Immunol; 2021 Feb; 203(2):219-229. PubMed ID: 33030251
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
19. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
20. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]